Coherus BioSciences (United States)
company in Redwood City, United States
CHRS Nasdaq
SEC CIK 1512762
Follow Coherus BioSciences (United States)
Weekly email: filings, results
Revenue, last quarter
$14.3M
+23.4% vs same quarter last year
Net income
−$39.3M
−10.7% vs same quarter last year
EPS, diluted
−$0.25
+19.4% vs same quarter last year
Operating cash flow
−$34M
+26.6% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $42.2M | $168M |
| FY24 | $26.4M | $28.5M |
| FY23 | $1.2M | −$237.9M |
| FY22 | $211M | −$291.8M |
| FY21 | $326.6M | −$287.1M |
| FY20 | $475.8M | $132.2M |
| FY19 | $356.1M | $89.8M |
| FY18 | $0 | −$209.3M |
| FY17 | $1.6M | −$238.2M |
| FY16 | $189.5M | −$127.3M |
| FY15 | $30M | −$223.3M |
| FY14 | $31.1M | −$87.1M |
| FY13 | $2.8M | −$53.6M |
| FY12 | $1.9M | −$33M |
| FY11 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 67.2% | −429.5% | 398.4% |
| FY24 | 66.9% | −756.6% | 108% |
| FY23 | 64% | −17716.6% | −19531.4% |
| FY22 | 66.8% | −121.7% | −138.2% |
| FY21 | 82.4% | −80.8% | −87.9% |
| FY20 | 92.1% | 32.9% | 27.8% |
| FY19 | 95.2% | 30.3% | 25.2% |
| FY18 | - | - | - |
| FY17 | - | −14918.8% | −15306.6% |
| FY16 | - | −61.2% | −67.2% |
| FY15 | - | −729.2% | −743.2% |
| FY14 | - | −207.9% | −280.1% |
| FY13 | - | −1308.4% | −1949.7% |
| FY12 | - | −2028.3% | −1738.7% |
| FY11 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | −$175.2M |
| FY22 | −$243.2M |
| FY21 | −$38.7M |
| FY20 | $146.9M |
| FY19 | $26.5M |
| FY18 | −$160.1M |
| FY17 | −$204.9M |
| FY16 | −$259.1M |
| FY15 | −$114.2M |
| FY14 | −$26.8M |
| FY13 | $15.1M |
| FY12 | −$20M |
| FY11 | - |
- Coherus BioSciences (United States)
- Healthcare median
Show the numbers
| Year | Coherus BioSciences (United States) | Healthcare median |
|---|---|---|
| FY25 | 398.4% | −30.6% |
| FY24 | 108% | −47% |
| FY23 | −19531.4% | −58% |
| FY22 | −138.2% | −80.4% |
| FY21 | −87.9% | −71.9% |
| FY20 | 27.8% | −62.2% |
| FY19 | 25.2% | −46.3% |
| FY18 | - | −49.6% |
| FY17 | −15306.6% | −45.9% |
| FY16 | −67.2% | −36% |
| FY15 | −743.2% | −38.4% |
| FY14 | −280.1% | −35.5% |
| FY13 | −1949.7% | −37.1% |
| FY12 | −1738.7% | −29.1% |
| FY11 | - | −27.9% |